Schroders Capital Global Innovation Trust announces weak financial results for 2023
LONDON: In a news release, Schroders Capital Global Innovation Trust plc (INOV) has announced its final results for the fiscal year ending December 31, 2023....
Schroders Capital Global Innovation Trust invests in Neurona Therapeutics
LONDON, UK: Schroders Capital Global Innovation Trust has made an investment of $1.6 million (£1.3 million) in Neurona Therapeutics, a US-based clinical-stage cell therapy company....
Schroders Capital Global Innovation Trust makes investment in Memo Therapeutics
LONDON: Schroders Capital Global Innovation Trust has made a commitment of CHF 0.9 million (£0.8 million) to Memo Therapeutics AG, a Switzerland-based clinical-stage biopharmaceutical company....